# K120722: Rival Pta Dilatation Catheter

- Pathway: 510(k) (Traditional)
- Applicant: Bard Peripheral Vascular, Inc.
- Decided: Apr 19, 2012 after 41 days
- Product code: LIT (Catheter, Angioplasty, Peripheral, Transluminal)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K001134 (2000). 18 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 20 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K052149: Edwards Peripheral Dilation Catheter, Edwards Lifesciences, LLC (2005) Summary page 1.
- K072283: Dorado Pta Balloon Dilatation Catheter, Bard Peripheral Vascular, Inc. (2007) Summary page 1.

## Most influential descendants
- K142261: Ultraverse 035 PTA Balloon Dilatation Catheter (2014), 0 descendants of its own

## Indications for use
The Rivalo PTA Dilatation Catheters are intended to dilate stenoses in the peripheral arteries, treat obstructive lesions of native or synthetic A-V fistulae, and/or re-expand endoluminal stent graft elements in the aorta and iliac arteries. This device is also recommended for post-dilatation of balloon expandable and self-expanding stents in the peripheral vasculature.

Source page: https://510kreport.com/device/K120722
Methodology: https://510kreport.com/methodology
